反流扩展指数:一种量化女性C1-C2期慢性静脉疾病大隐静脉反流负荷的新工具
该横断面研究纳入1138例女性(2276条肢体)C1或C2期慢性静脉疾病患者,用Pittaluga下肢标测将反流区域数分为REXI-0至REXI-3四个等级。结果显示REXI等级与C2分类概率呈单调递增关系,校正后AUROC为0.837,提示REXI是一种简单可量化的反流扩展评估框架。
要点
- REXI等级越高,双侧C2概率越大,REXI-3校正OR达51.97。
- 校正后模型区分度良好,AUROC为0.837。
- 42.1%的双侧C2女性REXI为0或1,反流负荷轻微。
核心结论
- REXI是量化早期慢性静脉疾病女性大隐静脉反流扩展的简单、可量化、临床适用的序数框架。
- REXI等级与C2分类概率单调相关,区分度良好。
研究设计与样本
- 横断面研究,纳入2019年1月至2023年7月在一家私立静脉学诊所就诊的≥18岁女性,临床检查及双功能超声分类为C1或C2期。
- 共1138例(2276条肢体)符合标准,所有检查由单一操作者完成。
主要发现
- 肢体水平C2患病率随REXI类别单调增加。
- 患者水平双侧C2 vs REXI-0的校正OR:REXI-1为5.26(95%CI 3.34-8.29),REXI-2为14.93(95%CI 9.31-23.95),REXI-3为51.97(95%CI 25.53-105.81),均P<.001。
- 粗AUROC 0.815(95%CI 0.783-0.847),校正后0.837(95%CI 0.805-0.868),ΔAUROC +0.022,P=.001。
- 校正后C2概率在REXI-1与REXI-2之间越过50%(56.6%,95%CI 48.3-64.9)。
- 左侧C2优势(McNemar OR 1.34,95%CI 1.04-1.74,P=.026);240例双侧C2女性中101例(42.1%)为REXI-0/REXI-1。
关键数值与推荐
- 反流区域数(0-12,Pittaluga下肢标测)分为REXI-0(0)、REXI-1(1-2)、REXI-2(3-5)、REXI-3(≥6)。
- REXI-1至REXI-3的校正OR分别为5.26、14.93、51.97(均P<.001),McFadden伪R²=0.280。
临床怎么用
- REXI可作为临床量化大隐静脉反流扩展的简易工具,辅助区分C1与C2期患者。
- REXI等级较高提示C2概率增加,可帮助识别反流负荷较重的早期患者。
局限性
- 单中心、私立诊所、单一操作者,结果外推需谨慎。
- 作者指出需前瞻性多中心验证和干预结局研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study aimed to describe and quantify saphenous reflux patterns in women with early chronic venous disease (Clinical-Etiological-Anatomical-Pathophysiological classes C1 and C2), evaluate the ability of these patterns to discriminate between C1 and C2, and identify whether a greater extent of saphenous reflux corresponds to a greater probability of C2 classification. METHODS: Cross-sectional study of women ≥18 years classified as Clinical-Etiological-Anatomical-Pathophysiological classes C1 or C2 by clinical examination and duplex ultrasound study between January 2019 and July 2023 at a private phlebology clinic; met inclusion criteria 1138 (2276 limbs); all examinations were performed by a single operator. The number of zones with reflux (0-12, Pittaluga lower-limb mapping) was binned into Reflux Extension Index (REXI-0; 0), REXI-1 (1-2), REXI-2 (3-5), and REXI-3 (≥6). Analyses were conducted at the limb level (n = 2276) and at the patient level for concordant subgroups (bilateral: C1, n = 666; C2, n = 240; total: n = 906). Logistic regression, adjusted for age and family history, was performed in 885 women with complete data. Model discrimination was assessed using the area under the receiver-operating characteristic curve (AUROC), monotonic trend within a generalized estimating equation framework, and McNemar test. RESULTS: At the limb level, C2 prevalence increased monotonically with REXI category. At the patient level, adjusted odds ratios for bilateral C2 vs REXI-0 were 5.26 [95% confidence interval (CI), 3.34-8.29], 14.93 (95% CI, 9.31-23.95), and 51.97 (95% CI, 25.53-105.81) for REXI-1 to REXI-3 (all P < .001; McFadden pseudo-R2 = 0.280). Discrimination was good and improved with adjustment: crude AUROC 0.815 (95% CI, 0.783-0.847), adjusted 0.837 (95% CI, 0.805-0.868); and ΔAUROC, +0.022; P = .001. The adjusted probability of C2 crossed 50% between REXI-1 and REXI-2 (56.6%; 95% CI, 48.3-64.9). A left-sided C2 predominance was observed (McNemar odds ratio, 1.34; 95% CI, 1.04-1.74; P = .026). Of 240 women with bilateral C2, 101 (42.1%) had a REXI-0/REXI-1 profile-minimal or no saphenous reflux. CONCLUSIONS: REXI is a simple, quantitative, and clinically applicable ordinal framework for measuring saphenous reflux extension in women with early chronic venous disease. Prospective multicenter validation and interventional outcome studies are the necessary next steps.
引用
- Sathler de Melo CC, Miranda Júnior F, Sanudo A, et al. Reflux Extension Index as a novel ordinal tool for quantifying saphenous reflux burden in women with Clinical-Etiological-Anatomical-Pathophysiological classes C1 to C2 chronic venous disease. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42858948. doi:10.1016/j.jvsv.2026.102640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。